
| Salt Composition: | Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg) |
| Manufacturer: | Koye Pharmaceuticals Pvt ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Glimipack MV 1mg/500mg/0.2mg Tablet is an anti-diabetic drug used to treat type 2 diabetes mellitus in adults by controlling blood sugar levels. Glimipack MV 1mg/500mg/0.2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. The medicine should be taken with food to avoid an upset stomach and can cause hypoglycemia when used with other antidiabetic medicines, alcohol, or if a meal is delayed or missed. Regular liver function checks may be necessary, and any symptoms like abdominal pain, loss of appetite, or jaundice should be reported to a doctor.
Glimipack MV 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines.
What is Glimipack MV 1mg/500mg/0.2mg Tablet?
Glimipack MV 1mg/500mg/0.2mg Tablet is a combination medication containing glimepiride, metformin, and voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, in conjunction with a healthy diet and regular exercise. Glimepiride increases insulin release from the pancreas, while metformin reduces glucose production in the liver and improves insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose levels. This medication is not suitable for treating type 1 DM.
What are the possible side effects of Glimipack MV 1mg/500mg/0.2mg Tablet?
Common side effects of Glimipack MV 1mg/500mg/0.2mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any of these symptoms, consult your doctor or healthcare provider.
Are there any specific conditions in which Glimipack MV 1mg/500mg/0.2mg Tablet should not be taken?
Glimipack MV 1mg/500mg/0.2mg Tablet should be avoided in patients with known allergies to its components or excipients. Additionally, it is contraindicated in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Glimipack MV 1mg/500mg/0.2mg Tablet?
No, it is not recommended to consume alcohol while taking Glimipack MV 1mg/500mg/0.2mg Tablet. This may increase the risk of hypoglycemia and lactic acidosis. Consult your doctor or healthcare provider for personalized advice.
Can the use of Glimipack MV 1mg/500mg/0.2mg Tablet cause hypoglycemia?
Yes, Glimipack MV 1mg/500mg/0.2mg Tablet can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to occur if you miss or delay meals, drink alcohol, over-exercise, or take other antidiabetic medications. Regularly monitor your blood sugar levels and keep glucose tablets, honey, or fruit juice nearby.
What are the instructions for the storage and disposal of Glimipack MV 1mg/500mg/0.2mg Tablet?
Store Glimipack MV 1mg/500mg/0.2mg Tablet in its original packaging, tightly closed. Follow the storage instructions provided on the packaging or label. Dispose of unused medication properly, ensuring it is not consumed by pets, children, or other individuals.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimipack MV 1mg/500mg/0.2mg Tablet is to be taken on an empty stomach.
Alcohol
It is unsafe to consume alcohol with Glimipack MV 1mg/500mg/0.2mg Tablet.
Breastfeed
Glimipack MV 1mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Glimipack MV 1mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.